Ivermectin shows us how hard it is to use old drugs for COVID. Here's how to do better next time

By Jonathan Baell, Research Professor in Medicinal Chemistry and Drug Discovery, Monash Institute of Pharmaceutical Sciences, Monash University
Michael Jennings, Professor and Deputy Director/NHMRC Fellow, Institute for Glycomics, Griffith University
Michael Parker, Professor Biochemistry and Pharmacology and Director, Bio21 Institute, The University of Melbourne

The path to using old drugs for COVID is full of potholes. So why are we using the same old flawed methods when we actually know what works?

Read complete article

~	Inside Germany's Orwellian crackdown on Palestine Congress

~	Newly uncovered Helen of Troy fresco shows Pompeii’s elite were eager for ancient Greek stories about women

~	London Marathon: how visually impaired people run

~	Crucial building blocks of life on Earth can more easily form in outer space – new research

~	Hard work and happy accidents: why do so many of us prefer ‘difficult’ analogue technology?

~	How a teenager helped identify a new species of giant marine reptile

~	Cities with Black women police chiefs had less street violence during 2020’s Black Lives Matter protests

~	5 years after the Mueller report into Russian meddling in the 2016 US election on behalf of Trump: 4 essential reads

~	AI chatbots refuse to produce ‘controversial’ output − why that’s a free speech problem

~	3 things to learn about patience − and impatience − from al-Ghazali, a medieval Islamic scholar